Adage Capital Partners
TYRA icon

Adage Capital Partners’s Tyra Biosciences TYRA Stock Holding History

Adage Capital Partners’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.17M Buy
+162,000
New +$5.36M 0.01% 807
2025
Q1 		– Sell
-200,000
Closed -$2.78M – 948
2024
Q4 		$2.78M Hold
200,000
– – ﹤0.01% 771
2024
Q3 		$4.7M Buy
+200,000
New +$4.2M 0.01% 723

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Adage Capital Partners's TYRA Position: Q2 2026 in Review

Adage Capital Partners opened a new position in Tyra Biosciences (TYRA) in Q2 2026: 162,000 shares worth $5.17M. The stake represents 0.01% of the portfolio and ranks #807 among its holdings. This is a return to the name: Adage Capital Partners previously reported a position in TYRA as recently as Q4 2024.

Adage Capital Partners first reported a position in TYRA in Q3 2024 and has held it in 3 quarters since. 169 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

  • Adage Capital Partners held 162,000 shares of Tyra Biosciences worth $5.17M as of Q2 2026.
  • Tyra Biosciences was a new Adage Capital Partners position in Q2 2026.
  • Tyra Biosciences made up 0.01% of Adage Capital Partners's portfolio in Q2 2026, its #807 holding.
  • Adage Capital Partners first reported a position in Tyra Biosciences in Q3 2024 and has held it in 3 quarters since.
  • 169 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on Adage Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.